These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34193335)

  • 1. Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England.
    Subbarao S; Campbell H; Ribeiro S; Clark SA; Lucidarme J; Ramsay M; Borrow R; Ladhani S
    Emerg Infect Dis; 2021 Sep; 27(9):2495-2497. PubMed ID: 34193335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in England.
    Clark SA; Campbell H; Ribeiro S; Bertran M; Walsh L; Walker A; Willerton L; Lekshmi A; Bai X; Lucidarme J; Ladhani SN; Borrow R
    J Infect; 2023 Nov; 87(5):385-391. PubMed ID: 37689395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive Meningococcal X Disease during the COVID-19 Pandemic, Brazil.
    Fukasawa LO; Liphaus BL; Gonçalves MG; Higa FT; Camargo CH; Carvalhanas TRMP; Lemos APS
    Emerg Infect Dis; 2022 Sep; 28(9):1931-1932. PubMed ID: 35997471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review.
    Alderson MR; Arkwright PD; Bai X; Black S; Borrow R; Caugant DA; Dinleyici EC; Harrison LH; Lucidarme J; McNamara LA; Meiring S; Sáfadi MAP; Shao Z; Stephens DS; Taha MK; Vazquez J; Zhu B; Collaborators G
    J Infect; 2022 Mar; 84(3):289-296. PubMed ID: 34838594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
    Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
    Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pandemic's influence on parents' attitudes and behaviors toward meningococcal vaccination.
    Tan LLJ; Safadi MAP; Horn M; Regojo Balboa C; Moya E; Schanbaum J; Pimenta P; Lambert E; Soumahoro L; Sohn WY; Bruce T; Ruiz García Y
    Hum Vaccin Immunother; 2023 Dec; 19(1):2179840. PubMed ID: 36883777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines.
    Ladhani SN; Flood JS; Ramsay ME; Campbell H; Gray SJ; Kaczmarski EB; Mallard RH; Guiver M; Newbold LS; Borrow R
    Vaccine; 2012 May; 30(24):3710-6. PubMed ID: 22429756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Did social distancing measures deployed for SARS-CoV-2/COVID-19 control have an impact on invasive meningococcal disease?
    Stefanelli P; Fazio C; Vacca P; Neri A; Ambrosio L; Rezza G
    Pathog Glob Health; 2022 Jun; 116(4):263-265. PubMed ID: 34844520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal Group W Disease in Infants and Potential Prevention by Vaccination.
    Parikh SR; Campbell H; Beebeejaun K; Ribeiro S; Gray SJ; Borrow R; Ramsay ME; Ladhani SN
    Emerg Infect Dis; 2016 Aug; 22(8):1505-7. PubMed ID: 27433852
    [No Abstract]   [Full Text] [Related]  

  • 10. Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines.
    Stein-Zamir C; Shoob H; Abramson N; Block C; Keller N; Jaffe J; Valinsky L
    Hum Vaccin Immunother; 2019; 15(1):242-248. PubMed ID: 30156954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive meningococcal disease: Timing and cause of death in England, 2008-2015.
    Beebeejaun K; Parikh SR; Campbell H; Gray S; Borrow R; Ramsay ME; Ladhani SN
    J Infect; 2020 Mar; 80(3):286-290. PubMed ID: 31904388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of surveillance: Group W meningococcal disease outbreak response and control in England.
    Campbell H; Ladhani S
    Int Health; 2016 Nov; 8(6):369-371. PubMed ID: 27620924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suspected cluster of
    Lawler J; Lucidarme J; Parikh S; Smith L; Campbell H; Borrow R; Gray S; Foster K; Ladhani S
    Euro Surveill; 2019 Jun; 24(23):. PubMed ID: 31186079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of invasive meningococcal disease: is it achievable?
    Marshall H; Wang B; Wesselingh S; Snape M; Pollard AJ
    Int J Evid Based Healthc; 2016 Mar; 14(1):3-14. PubMed ID: 26126001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unwanted guest: Neisseria meningitidis - carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence.
    Gianchecchi E; Piccini G; Torelli A; Rappuoli R; Montomoli E
    Expert Rev Anti Infect Ther; 2017 Jul; 15(7):689-701. PubMed ID: 28524748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease.
    Taha MK; Deghmane AE
    BMC Res Notes; 2020 Aug; 13(1):399. PubMed ID: 32854773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons for and from the COVID-19 pandemic response - An appraisal of guidance for the public health management of Invasive Meningococcal Disease.
    Morello BR; Milazzo A; Marshall HS; Giles LC
    J Infect Public Health; 2021 Aug; 14(8):1069-1074. PubMed ID: 34218099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England.
    Ladhani SN; Andrews N; Parikh SR; Campbell H; White J; Edelstein M; Bai X; Lucidarme J; Borrow R; Ramsay ME
    N Engl J Med; 2020 Jan; 382(4):309-317. PubMed ID: 31971676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
    Cohen R; Levy C
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England.
    Campbell H; Andrews N; Parikh S; Ribeiro S; Gray S; Lucidarme J; Ramsay ME; Borrow R; Ladhani SN
    J Infect; 2020 Feb; 80(2):182-189. PubMed ID: 31715210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.